|Slideshows|February 17, 2022

The Heart of Psychiatry

For American Heart Month, catch up on all the latest in psychocardiology.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Subscribe

Related Content

Metabolic & Mental Health: A Conversation With Benjamin I. Perry, PhD; Nicolette Stogios, PhD; and Katharine Liang, MD, PhD

ByJessica M. Gannon, MD,Benjamin I. Perry, PhD,Nicolette Stogios, PhD,Katharine Liang, MD, PhD

July 9th 2026

Podcast: A Transdiagnostic Approach to Metabolic Health and Mental Illness

ByJessica M. Gannon, MD,Benjamin I. Perry, PhD,Nicolette Stogios, PhD,Katharine Liang, MD, PhD

July 9th 2026

Psychiatric Comorbidities in Adults With Congenital Heart Disease and the Need for Interdisciplinary Care

BySophia Hashmi,Hazem Shahin, MD

June 24th 2026

Addressing Sexual Wellness: A Psychiatric Perspective

ByGrace L. Johnson, MD,Alex Rains, MD,Renee Sorrentino, MD

June 11th 2026

Evaluating Glucagon-Like Peptide-1 Receptor Agonists and Mental Health Outcomes

ByMasha Impallaria, MD,Caitlin Leconte, MD,Irina Matsneva, MD,Albert Dickan, MD,Haley Schuster, MD,Mark Mullen, MD,Rajesh R. Tampi, MD, MS, DFAPA, DFAAGP

May 11th 2026

Latest CME

Video

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Video

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

Video

Expert Illustrations & Commentary: Visualizing the Role of Novel Muscarinic Agents in the Management of Schizophrenia

Ilan Melnick, MD; Linda Collado, MD, DABPN, FAPA; Maria Collado, MD, FAPA

Video

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

John Koo, MD; T.J. Chao, MPAS, PA-C

Video

Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Patricia Junquera, MD; Maria Collado, MD; Erin C. Crown, MHSPAS, PA-C, Psych-CAQ

Video

Expert Illustrations & Commentary: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Juan D. Oms, MD, FAPA; Linda Collado, MD, DABPN, FAPA; Ginger Shupe, MD

Video

(CPE Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Video

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

The Heart of Psychiatry

Related Content

Metabolic & Mental Health: A Conversation With Benjamin I. Perry, PhD; Nicolette Stogios, PhD; and Katharine Liang, MD, PhD

Podcast: A Transdiagnostic Approach to Metabolic Health and Mental Illness

Psychiatric Comorbidities in Adults With Congenital Heart Disease and the Need for Interdisciplinary Care

Addressing Sexual Wellness: A Psychiatric Perspective

Evaluating Glucagon-Like Peptide-1 Receptor Agonists and Mental Health Outcomes

Latest CME

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Expert Illustrations & Commentary: Visualizing the Role of Novel Muscarinic Agents in the Management of Schizophrenia

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Expert Illustrations & Commentary: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

(CPE Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Trending on Psychiatric Times

Antipsychotic Misadventures

Vol 43, Issue 7 - Interactive

FDA Accepts NDA for AXS-12 for the Treatment of Cataplexy in Narcolepsy

Beyond Deprescribing: A Formula for Excellent Clinical Care

AI Chatbots and the Erosion of Therapeutic Discomfort